Ratings by Summer Street
| Date | Company | Symbol | Type | Rating (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2013 | Conceptus | CPTS | Downgrade | Neutral (Buy) |
30.96 | 30.95 | -0.03% | Details |
| 3/6/2013 | Conceptus | CPTS | Upgrade | Buy (Neutral) |
22.66 | 30.96 | 36.63% | Details |
| 2/20/2013 | BioMimetic Therapeutics | BMTI | Downgrade | Neutral (Buy) |
8.85 | 9.49 | 7.23% | Details |
| 1/30/2013 | Zimmer Holdings | ZMH | Downgrade | Neutral (Buy) |
75.42 | 79.75 | 5.74% | Details |
| 1/24/2013 | Dendreon | DNDN | Maintain | Buy (N/A) |
Details | |||
| 11/20/2012 | Endocyte | ECYT | New Coverage | Buy (N/A) |
7.75 | 13.95 | 80% | Details |
| 11/15/2012 | Puma Biotechnology | PBYI | Downgrade | Neutral (Buy) |
16.50 | 38.49 | 133.27% | Details |
| 11/6/2012 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
Details | |||
| 11/5/2012 | MAKO Surgical | MAKO | Upgrade | Buy (Neutral) |
15.40 | 11.27 | -26.82% | Details |
| 10/17/2012 | ISIS Pharmaceuticals | ISIS | Downgrade | Neutral (Buy) |
10.27 | 20.75 | 102.04% | Details |
| 10/4/2012 | NuVasive | NUVA | Downgrade | Neutral (Buy) |
14.97 | 22.24 | 48.56% | Details |
| 7/27/2012 | AMAG Pharmaceuticals | AMAG | Upgrade | Buy (Neutral) |
15.25 | 22.00 | 44.26% | Details |
| 7/17/2012 | Human Genome Sciences | HGSI | Downgrade | Neutral (Buy) |
14.19 | 14.24 | 0.35% | Details |
| 7/10/2012 | MAKO Surgical | MAKO | Downgrade | Neutral (Buy) |
14.73 | 15.40 | 4.55% | Details |
| 6/13/2012 | Dendreon | DNDN | New Coverage | Buy (N/A) |
6.25 | 3.89 | -37.76% | Details |
| 5/8/2012 | Vertex | VRTX | Maintain | Buy (N/A) |
Details | |||
| 4/11/2012 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
8.85 | 3.96 | -55.25% | Details |
| 4/3/2012 | Æterna Zentaris | AEZS | Downgrade | Neutral (N/A) |
0.73 | 2.04 | 179.45% | Details |
| 3/22/2012 | Synergy Pharmaceuticals | SGYP | New Coverage | Buy (N/A) |
4.15 | 5.09 | 22.65% | Details |
| 3/7/2012 | MAKO Surgical | MAKO | Maintain | Buy (N/A) |
Details | |||
| 3/2/2012 | Anthera Pharma | ANTH | New Coverage | Buy (N/A) |
6.46 | 0.60 | -90.71% | Details |
| 1/30/2012 | Amylin Pharmaceuticals | AMLN | Downgrade | Neutral (N/A) |
12.14 | 30.98 | 155.19% | Details |
| 1/13/2012 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
11.97 | 28.06 | 134.42% | Details |
| 1/3/2012 | MAKO Surgical | MAKO | Upgrade | Buy (N/A) |
25.21 | 14.73 | -41.57% | Details |
| 12/13/2011 | Avanir Pharmaceuticals | AVNR | Maintain | Buy (N/A) |
Details | |||
| 11/22/2011 | Gilead Sciences | GILD | Downgrade | Neutral (N/A) |
36.26 | 55.53 | 53.14% | Details |
| 10/25/2011 | Adolor | ADLR | Downgrade | Neutral (N/A) |
4.67 | 4.77 | 2.14% | Details |
| 10/18/2011 | Medivation | MDVN | New Coverage | Buy (N/A) |
8.21 | 49.89 | 507.67% | Details |
| 10/6/2011 | Curis | CRIS | New Coverage | Buy (N/A) |
3.26 | 3.76 | 15.34% | Details |
| 10/5/2011 | Seattle Genetics | SGEN | New Coverage | Sell (N/A) |
20.34 | 35.47 | 74.39% | Details |
| 9/19/2011 | MAKO Surgical | MAKO | New Coverage | Neutral (N/A) |
36.27 | 25.21 | -30.49% | Details |
| 9/19/2011 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
2.60 | 1.94 | -25.38% | Details |
| 9/19/2011 | BioMimetic Therapeutics | BMTI | New Coverage | Buy (N/A) |
4.04 | 8.85 | 119.06% | Details |
| 9/19/2011 | TranS1 Inc | TSON | New Coverage | Buy (N/A) |
3.70 | 1.93 | -47.84% | Details |
| 9/19/2011 | Tornier | TRNX | New Coverage | Buy (N/A) |
21.69 | 16.92 | -21.99% | Details |
| 9/19/2011 | Anika Therapeutics | ANIK | New Coverage | Buy (N/A) |
5.74 | 13.85 | 141.29% | Details |
| 9/19/2011 | NuVasive | NUVA | New Coverage | Buy (N/A) |
22.13 | 22.62 | 2.21% | Details |
| 8/31/2011 | Immunomedics | IMMU | New Coverage | Buy (N/A) |
3.98 | 3.27 | -17.84% | Details |
| 8/25/2011 | ARIAD Pharmaceuticals | ARIA | New Coverage | Buy (N/A) |
8.83 | 19.46 | 120.39% | Details |
| 8/23/2011 | Onyx Pharmaceuticals | ONXX | New Coverage | Buy (N/A) |
29.76 | 96.11 | 222.95% | Details |
| 8/2/2011 | Conceptus | CPTS | New Coverage | Neutral (N/A) |
11.21 | 22.66 | 102.14% | Details |
| 7/21/2011 | AMAG Pharmaceuticals | AMAG | Downgrade | Neutral (N/A) |
16.24 | 15.25 | -6.1% | Details |
| 7/18/2011 | Adolor | ADLR | New Coverage | Buy (N/A) |
2.43 | 4.67 | 92.18% | Details |
| 5/4/2011 | Æterna Zentaris | AEZS | New Coverage | Buy (N/A) |
2.24 | 0.73 | -67.41% | Details |
| 3/14/2011 | AMAG Pharmaceuticals | AMAG | Upgrade | Buy (N/A) |
16.89 | 19.07 | 12.91% | Details |
| 1/19/2011 | Exactech Inc | EXAC | New Coverage | Buy (N/A) |
17.01 | 17.87 | 5.06% | Details |
| 12/23/2010 | Arena Pharma | ARNA | Upgrade | Neutral (N/A) |
1.80 | 8.06 | 347.78% | Details |
| 9/29/2010 | ViroPharma | VPHM | New Coverage | Neutral (N/A) |
15.22 | 26.73 | 75.62% | Details |
| 9/15/2010 | Arena Pharma | ARNA | Downgrade | Sell (N/A) |
4.13 | 1.80 | -56.42% | Details |
